Leadership

Unparalleled Expertise Guiding the Revolution in Programmable Medicines

LeadershipBoard of DirectorsAdvisory Team

Leadership

Tuyen Ong, MD, MBA

Chief Executive Officer, Ring Therapeutics & CEO Partner, Flagship Pioneering

Tuyen_large-headshot@2x

Konstantin Konstantinov, Ph.D.

Chief Technology Officer

elt-konstantinov-circle

Christopher McNulty

Chief Financial Officer, Head of Corporate Strategy

CMcnulty Headshot-correction-circle

Kelly Morgan, PhD, JD

Senior Vice President, Head of Legal

Kelly Morgan Headshot circle

Anne Osborne, MS

Vice President, Program Management

Anne_large-headshot_2x

Geoffrey Parsons, PhD

Senior Vice President, Head of Research

Geoffrey Parsons_edit-Circle

Megan Woods, MBA

Chief People Officer

Megan_large-headshot@2x

Christopher Wright, MD, PhD

Chief Medical Officer, Head of Translational Research

wright_smile1_crop-CIRCLE

Board of Directors

Tuyen Ong, MD, MBA

CEO, Ring Therapeutics; CEO Partner, Flagship Pioneering

Travis Wilson

Chairman of Board of Directors, Ring Therapeutics; Growth Partner, Flagship Pioneering

Avak Kahvejian, PhD

Founder, Ring Therapeutics; Partner, Flagship Pioneering

Francois Nader, MD, MBA

Chairman of the Board of Directors, BenevolentAI; Former CEO, NPS Pharma

B. Lynne Parshall, Esq

Strategic Advisor and Former COO, Ionis Pharmaceuticals

Hari Pujar, PhD, MBA

COO, Tessera Therapeutics, Operating Partner, Flagship Pioneering

Advisory Team

Aravind Asokan, PhD

Professor and Director of Gene Therapy, Duke University

Guangping Gao, PhD

Professor & Director of Horae Gene Therapy Center and Viral Vector Core, UMass Medical School

Mark Kay, MD, PhD

Professor, Stanford University

R. Jude Samulski, PhD

Co-founder, AskBio; Former Director, UNC Gene Therapy Center